TCOT
EDIT icon

Trust Company of Toledo’s Editas Medicine EDIT Stock Holding History

Trust Company of Toledo’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.62K Hold
500
– – ﹤0.01% 812
2026
Q1 		$1.24K Hold
500
– – ﹤0.01% 759
2025
Q4 		$1.02K Hold
500
– – ﹤0.01% 737
2025
Q3 		$1.74K Hold
500
– – ﹤0.01% 735
2025
Q2 		$1.1K Buy
+500
New +$818 ﹤0.01% 733

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Trust Company of Toledo's EDIT Position: Q2 2026 in Review

Trust Company of Toledo held its Editas Medicine (EDIT) position steady in Q2 2026 at 500 shares worth $1.62K. The position accounts for ﹤0.01% of the portfolio, ranked #812.

Trust Company of Toledo first reported a position in EDIT in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.74K in Q3 2025. 214 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Trust Company of Toledo held 500 shares of Editas Medicine worth $1.62K as of Q2 2026.
  • Trust Company of Toledo left its Editas Medicine share count unchanged in Q2 2026.
  • Editas Medicine made up ﹤0.01% of Trust Company of Toledo's portfolio in Q2 2026, its #812 holding.
  • Trust Company of Toledo first reported a position in Editas Medicine in Q2 2025 and has held it in 5 quarters since.
  • Trust Company of Toledo's Editas Medicine position peaked at $1.74K in Q3 2025.
  • 214 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Trust Company of Toledo's 13F filing for Q2 2026, filed 16 Jul 2026.